Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
The present invention refers to a process to prepare a highly activated composite of one or more water-insoluble drugs, said process comprising the steps of: (a) subjecting said water-insoluble drug and a cross-linked polymer to co-grinding; (b) exposing the ground product of step a. to contact with water or water vapors. The resulting composite contains large amounts of drug in the easily soluble amorphous form, reduced amounts of drug in the nanocrystalline form, and is substantially free from practically insoluble drug crystals.
1. A process to prepare a pharmaceutical form of one or more water-insoluble drugs, consisting of the following steps:
(a) co-grinding a water-insoluble drug and a cross-linked polymer in dry conditions to provide a ground product containing the water-insoluble drug;
(b) exposing the ground product to exclusively water or water vapours to provide a composite, wherein the water-insoluble drug present in the composite has a decreased residual crystallinity and decreased nanocrystal fraction and size, as measured by differential scanning calorimetry, compared to the water-insoluble drug prior to co-grinding;
(c) drying the composite of (b) in order to eliminate absorbed water; and
(d) processing the dried composite of (c) into a pharmaceutical form.
2. The process according to claim 1 , wherein said co-grinding is performed under high energy conditions.
3. The process according to claim 1 , wherein said cross-linked polymer is selected from the group consisting of cross-linked polyvinylpyrrolidone, cross-linked sodium carboxymethylcellulose, starch, sodium starch glycolate, pregelatinized starch, and polacrilin potassium.
4. The process according to claim 1 , wherein the weight ratio of cross-linked polymer to drug is from 12:1 to 0.5:1.
5. The process according to claim 1 , wherein step (a) is performed for from 1 hour to 6 hours.
6. The process according to claim 1 , wherein exposing the ground product to water or water vapour is performed for from 5 minutes to 120 minutes.
7. The process according to claim 1 , wherein in step (b) the ground product is maintained in an agitated status.
8. The process according to claim 1 , wherein the ground product/water weight ratio is from 1:0.05 to 1:5.
9. The process according to claim 1 , wherein the ground product/water weight ratio is from 1:0.1 to 1:3.
10. The process according to claim 1 , wherein the weight ratio of cross-linked polymer to drug is from 5:1 to 1:1.